See more : Stran & Company, Inc. (STRN) Income Statement Analysis – Financial Results
Complete financial analysis of MediXall Group, Inc. (MDXL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MediXall Group, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Lattice Incorporated (LTTC) Income Statement Analysis – Financial Results
- Mangalam Cement Limited (MANGLMCEM.BO) Income Statement Analysis – Financial Results
- Inventec Besta Co.,Ltd (8201.TW) Income Statement Analysis – Financial Results
- Taylor Maritime Investments Limited (TMI.L) Income Statement Analysis – Financial Results
- Kunshan Huguang Auto Harness Co.,Ltd. (605333.SS) Income Statement Analysis – Financial Results
MediXall Group, Inc. (MDXL)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.medixall.com
About MediXall Group, Inc.
MediXall Group, Inc., together with its subsidiaries, develops and operates a healthcare marketplace platform to help consumers learn, decide, and pay for healthcare in ways that complement relationships with trusted doctors in the United States. The company offers Health Karma platform that provides medical and wellness services to individuals, employer groups, and third-party administrators. MediXall Group, Inc. was incorporated in 1998 and is based in Fort Lauderdale, Florida.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 59.27K | 15.00K | 0.00 | 2.69K | 1.86K | 22.23K | 0.00 | 0.00 | 0.00 | 42.50K | 0.00 |
Cost of Revenue | 3.20M | 3.07M | 2.53M | 1.37M | 1.71M | 836.63 | 192.16K | 109.87K | 0.00 | 0.00 | 0.00 |
Gross Profit | -3.14M | -3.05M | -2.53M | -1.37M | -1.71M | 21.40K | -192.16K | -109.87K | 0.00 | 42.50K | 0.00 |
Gross Profit Ratio | -5,296.21% | -20,349.52% | 0.00% | -51,065.21% | -92,010.17% | 96.24% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% |
Research & Development | 38.82K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 5.84M | 6.40M | 5.31M | 3.42M | 2.90M | 1.66M | 456.82K | 202.78K | 684.09K | 1.02M | 130.00K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 391.10K | 0.00 | 8.19 | 35.98 | 0.00 | 0.00 | 0.00 |
SG&A | 5.84M | 6.40M | 5.31M | 3.42M | 2.90M | 1.66M | 465.01K | 238.75K | 684.09K | 1.02M | 130.00K |
Other Expenses | 180.51K | -16.50K | 623.58K | 3.04M | -391.10K | 1.54B | 630.38K | 312.65K | 552.54K | 0.00 | 0.00 |
Operating Expenses | 59.27K | 6.38M | 5.93M | 3.42M | 2.90M | 1.66M | 465.01K | 238.75K | 684.09K | 1.02M | 130.00K |
Cost & Expenses | 6.60M | 6.38M | 5.93M | 3.42M | 2.90M | 1.66M | 657.16K | 348.62K | 684.09K | 1.02M | 130.00K |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 271.12K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.13K | -20.00K |
Depreciation & Amortization | 35.72K | 4.00K | 4.00K | 4.00K | 3.15K | 3.00K | 657.16K | 348.62K | 0.00 | 0.00 | -40.00K |
EBITDA | -6.52M | -6.12M | -5.93M | -3.42M | -2.89M | -1.56M | 0.00 | 0.00 | -684.09K | -979.06K | -170.00K |
EBITDA Ratio | -11,006.92% | -43,534.59% | 0.00% | -124,804.66% | -151,073.41% | -7,367.13% | 0.00% | 0.00% | 0.00% | -2,303.67% | 0.00% |
Operating Income | -6.54M | -6.53M | -5.93M | -3.42M | -2.90K | -1.64M | -657.16K | -348.62K | -684.09K | -979.06K | -130.00K |
Operating Income Ratio | -11,035.15% | -43,561.27% | 0.00% | -127,409.72% | -155.91% | -7,380.62% | 0.00% | 0.00% | 0.00% | -2,303.67% | 0.00% |
Total Other Income/Expenses | -290.10K | 182.22K | -623.58K | 0.00 | -86.67K | 0.00 | 0.00 | 0.00 | 0.00 | -9.13K | -21.91K |
Income Before Tax | -6.83M | -6.20M | -5.93M | -3.42M | -2.98M | -1.64M | -657.16K | -348.62K | -684.09K | -988.19K | -150.00K |
Income Before Tax Ratio | -11,524.63% | -41,350.94% | 0.00% | -127,409.72% | -160,572.07% | -7,380.62% | 0.00% | 0.00% | 0.00% | -2,325.16% | 0.00% |
Income Tax Expense | 0.00 | -165.72K | -202.30K | -101.91K | -86.67K | 0.00 | -657.16K | -348.62K | 0.00 | 0.00 | 0.00 |
Net Income | -6.83M | -6.03M | -5.93M | -3.42M | -2.98M | -1.64M | -657.16K | -348.62K | -684.09K | -988.19K | -150.00K |
Net Income Ratio | -11,524.63% | -40,245.78% | 0.00% | -127,409.72% | -160,572.07% | -7,380.62% | 0.00% | 0.00% | 0.00% | -2,325.16% | 0.00% |
EPS | -0.06 | -0.06 | -0.07 | -0.05 | -0.05 | -0.03 | -0.25 | -0.14 | -0.27 | -0.43 | -0.06 |
EPS Diluted | -0.06 | -0.06 | -0.07 | -0.05 | -0.05 | -0.03 | -0.25 | -0.14 | -0.27 | -0.43 | -0.06 |
Weighted Avg Shares Out | 116.66M | 104.20M | 90.63M | 74.13M | 65.01M | 54.84M | 2.60M | 2.54M | 2.52M | 2.28M | 2.52M |
Weighted Avg Shares Out (Dil) | 116.66M | 104.20M | 90.63M | 74.13M | 65.01M | 54.84M | 2.60M | 2.54M | 2.52M | 2.28M | 2.52M |
MediXall Group Launching New Campaign Through Health Karma in Support of Mental Health Awareness Month
Partner Program Fuels Medixall Group Subsidiary Sales
Technology Giants Flock to Healthcare Arena; MediXall Group Targets Additional Acquisitions
MediXall Group Reports Skyrocketed Conversion Rates for Health Karma Social Media Campaigns
MediXall Group Sets Its Strategy Apart From the Rest of the $3.8 Trillion US Healthcare Market
MediXall Group Announces Customer Expansion for Health Karma
Source: https://incomestatements.info
Category: Stock Reports